Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer

Melanie Seaton; Sarah Harbach; Joanne Oke; Thomas D. J. Walker; Jessica Dalton-O'Reilly; Julian Selley; Daniel R. Brison; James Bolton; Stefan Meyer; David Knight; Richard J. Edmondson; Christine K. Schmidt

doi:10.1002/ctm2.70557

Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (1) :e70557 DOI: 10.1002/ctm2.70557

LETTER TO THE JOURNAL

Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer

Author information +

¹. Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, School of Medical Sciences, Medicine and Health, University of Manchester, Manchester, UK

². Department of Gynaecological Oncology, Division of Cancer Sciences, Faculty of Biology, School of Medical Sciences, Medicine and Health, University of Manchester, Manchester, UK

³. Biological Mass Spectrometry Core Facility, Faculty of Biology, Medicine and Health, Manchester Academic Health, Science Centre, University of Manchester, Manchester, UK

⁴. Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK

⁵. Department of Reproductive Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK

⁶. Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

⁷. Department of Paediatric Haematology and Oncology, Royal Manchester Children's Hospital, Manchester, UK

⁸. Young Oncology Unit, The Christie NHS Foundation Trust, Manchester, UK

⁹. St Mary's Hospital, Central Manchester, NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

richard.edmondson@manchester.ac.uk

christine.schmidt@manchester.ac.uk

Show less

History +

PDF

Cite this article

Download citation ▾

Melanie Seaton, Sarah Harbach, Joanne Oke, Thomas D. J. Walker, Jessica Dalton-O'Reilly, Julian Selley, Daniel R. Brison, James Bolton, Stefan Meyer, David Knight, Richard J. Edmondson, Christine K. Schmidt. Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer. Clinical and Translational Medicine, 2026, 16(1): e70557 DOI:10.1002/ctm2.70557

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Labidi-Galy SI, Papp E, Hallberg D, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017; 8(1): 1-10.

[2]	Rocha AD, Long DJ, Drake WK, et al. First clinical feasibility and safety study of a novel multimodality fallopian tube imaging endoscope. Lasers Surg Med Published online 2025: 163-170.

[3]	Wisztorski M, Aboulouard S, Roussel L, et al. Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death Dis. 2023; 14(9).

[4]	Li H, Qi Z, Niu Y, et al. FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer. Oncogene. 2021; 40(40): 5938-5949.

[5]	Dufresne J, Bowden P, Thavarajah T, et al. The plasma peptides of ovarian cancer. Clin Proteomics. 2018; 15(1): 1-19.

[6]	Wang Y, Li L, Zhang X, Zhao X. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6. J Ovarian Res. 2022; 15(1): 1-12.

[7]	Liu Y, Cao H, Zhao Y, Shan L, Lan S. Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis. J Ovarian Res. 2022; 15(1): 1-9.

[8]	Bruand M, Barras D, Mina M, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021; 36(3).

[9]

Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009; 33(12): 1878-1885.

[10]	Vang R, Shih IM. Serous tubal intra-epithelial carcinoma: what do we really know at this point?. Histopathology. 2022; 81(5): 542-555.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.